Bleakley Financial Group’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,608
Closed -$246K 559
2024
Q4
$246K Buy
1,608
+535
+50% +$90.2K 0.01% 875
2024
Q3
$208K Sell
1,073
-759
-41% -$159K 0.01% 915
2024
Q2
$425K Sell
1,832
-231
-11% -$50.2K 0.01% 655
2024
Q1
$445K Sell
2,063
-228
-10% -$53.4K 0.01% 646
2023
Q4
$593K Buy
2,291
+270
+13% +$66.3K 0.02% 541
2023
Q3
$519K Sell
2,021
-638
-24% -$171K 0.02% 533
2023
Q2
$757K Buy
2,659
+118
+5% +$35.1K 0.02% 476
2023
Q1
$706K Sell
2,541
-45
-2% -$12.5K 0.02% 483
2022
Q4
$716K Buy
+2,586
New +$730K 0.03% 453

Other funds holding BIIB